申请人:BenevolentAl Bio Limited
公开号:US20210253572A1
公开(公告)日:2021-08-19
The present invention relates to certain imidazo[1,2-b]pyridazine compounds and the pharmaceutically acceptable salts of such compounds. The invention also relates to the processes for the preparation of the compounds, compositions containing the compounds, and the uses of such compounds and salts in treating diseases or conditions associated with tropomyosin-related kinase (Trk), activity. More specifically the invention relates to the compounds and their salts useful as inhibitors of Trk. Formula (I) wherein R
1
, R
2
, R
3
, R
4
and R
5
, L and Z are as defined herein.